首页 › 基金 › Fairmount Funds Management LLC › ELVN

Fairmount Funds Management LLC 对 ELVN 的持仓历史

ENLIVEN THERAPEUTICS INC · 医疗保健

Fairmount Funds Management LLC 在 Q3 2026 的 13F 申报中披露持有 ELVN(ENLIVEN THERAPEUTICS INC)1,855,644 股,市值约 US$85.1M,约占其申报组合的 5.33%,在其申报持仓中市值排名第 7 位。 Fairmount Funds Management LLC 最近 13 个申报季度中有 13 个季度披露了 ELVN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)1.86M 股
申报持仓市值$85.06M
组合权重5.33%
首次申报Q3 2023
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Fairmount Funds Management LLC 对 ELVN 的持仓演变

Fairmount Funds Management LLC 于 Q3 2023 首次披露 ELVN 持仓:2,131,369 股(约 US$29.1M)。 该持仓在 Q2 2026 达到峰值 1,855,644 股,市值约 US$94.2M。 在 13 次申报中,Fairmount Funds Management LLC 2 次增持、1 次减持、9 次保持不变。 最近一期申报(Q3 2026)显示持股 1,855,644 股、市值约 US$85.1M。 持仓曾出现大幅变动:Q1 2024 增持约 50% (随后一个季度股价上涨 33%)、Q1 2026 减持约 50% (随后一个季度股价上涨 29%)。

逐季持仓明细

季度股数金额变化
Q3 2023 2.13M $29.11M 新进
Q4 2023 2.13M $29.50M 持有
Q1 2024 3.20M $56.34M 增持
Q2 2024 3.20M $74.85M 持有
Q3 2024 3.20M $81.80M 持有
Q4 2024 3.20M $72.06M 持有
Q1 2025 3.20M $63.03M 持有
Q2 2025 3.71M $74.45M 增持
Q3 2025 3.71M $75.97M 持有
Q4 2025 3.71M $57.16M 持有
Q1 2026 1.86M $72.74M 减持
Q2 2026 1.86M $94.17M 持有
Q3 2026 1.86M $85.06M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ELVN 与 13F 数据

ELVN(ENLIVEN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 56 只申报持有 ELVN,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$310.6M), Polar Capital Holdings Plc (US$294.5M), Commodore Capital LP (US$150.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ELVN 的基金

查看 ELVN 的全部基金持有人 →

常见问题

How long has Fairmount Funds Management LLC held ELVN?

Fairmount Funds Management LLC has disclosed ELVN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Fairmount Funds Management LLC's current position in ELVN?

As of Q3 2026, Fairmount Funds Management LLC holds 1.86M shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $85.06M, representing 5.33% of its reported portfolio and ranking #7.

Has Fairmount Funds Management LLC been buying or selling ELVN?

In the latest 13F filing (Q3 2026), Fairmount Funds Management LLC held unchanged its position in ELVN. The position peaked in Q2 2026 at 1.86M shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Commodore Capital LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.